• Inicio
    • Bienvenida
    • Opiniones
    • FAQ
    • Aviso legal
    • Sellos de Calidad
  • Alzheimer
    • Síntomas de Alzheimer
    • Diagnóstico Alzheimer
    • Enfermedad de Alzheimer: ¿ Qué es y cómo se produce ?
    • Enfermedad de Alzheimer: ¿A Quién Afecta y Por Qué?
    • Enfermedad de Alzheimer: síntomas, diagnóstico y evolución
    • FAQ (Preguntas más frecuentes)
    • Glosario de términos
    • Estudios Alzheimer
    • Fases del Alzheimer
  • Cuidadores
    • Vídeos
    • Guías Alzheimer
    • Manual Básico Cuidadores
    • Descargas
    • Mapa de Cuidadores y Ex-Cuidadores Alzheimer en Google Maps
    • Descargas UPP
    • Úlceras por Presión
  • Descargas
  • Cartas 💌
    • Frases del Alzheimer
      • Frases sobre Alzheimer, Cerebro y Memoria…Segunda Parte (Actualizado 2017)
      •  Frases sobre Alzheimer (2019)
  • Juegos
    • Sudoku
    • Encuentra las Diferencias en el Zoo
    • Juegos para Ejercitar la Memoria (Nuevos)
    • Juegos Interactivos para Ejercitar la Memoria
    • Juegos interactivos para ejercitar la memoria 2
    • Mejorar la memoria y la atención
    • No te cruces en mi camino
  • Libros
    • Libros Alzheimer.
    • 25 Libros infantiles sobre Alzheimer
    • Un Libro Sobre cómo Vivir Más: Eludir el Alzheimer, Cáncer
    • Libro y Entrevista al Neurólogo Carlos Hernández Lahoz
    • Libro de vida: actividad de reminiscencia en Alzheimer
    • Exclusiva: Avance del nuevo libro de Pablo Barredo
    • Por los surcos del olvido. (Descarga el Libro Gratis!)
    • Los siete pecados cerebrales. (Descarga el Libro Gratis!)
    • Conociendo la enfermedad que llegó para quedarse (Libro gratis)
  • Opinión
  • Contacto

⠀⠀Blog Alzheimer

⠀⠀⠀⠀⠀Para Cuidadores

Ir a la Portada » Sin categoría » Spinal-Fluid Test Is Found to Predict Alzheimer’s

Spinal-Fluid Test Is Found to Predict Alzheimer’s

9 agosto, 2010 10:27 pm By Jesús Tj Dejar un comentario

Compartir es Amar
  • Facebook
  • Twitter
  • Linkedin
  • Pinterest
  • email
Researchers report that a spinal-fluid test can be 100 percent accurate in identifying patients with significant memory loss who are on their way to developing Alzheimer’s disease.
By GINA KOLATA
Published: August 9, 2010

Although there has been increasing evidence of the value of these tests in finding signs of Alzheimer’s, the study, which will appear Tuesday in the Archives of Neurology, shows how very accurate they can be.

“This is what everyone is looking for, the bull’s eye of perfect predictive accuracy,” said Dr. Steven DeKosky, dean of the University of Virginia’s medical school, who is not connected to the new research.

The study, said Dr. John Morris, a professor of neurology at Washington University, “establishes that there is a signature of Alzheimer’s and that it means something.It is very powerful.
A lot of work lies ahead, researchers say – making sure the tests are reliable if they’re used in doctors’ offices, making sure the research findings hold up in real life situations, getting doctors and patients comfortable with the notion of spinal taps, the method used to get spinal fluid. But they see a bright future.
The new study is part of a tsunami of recent findings on Alzheimer’s disease. After decades when nothing much seemed to be happening, when this progressive brain disease seemed untreatable and when its diagnosis could only be confirmed at autopsy, the field has suddenly woken up.
Alzheimer’s, investigators now agree, starts a decade or more before people have symptoms. And by the time there are symptoms it may be to late to save the brain. So the hope is to find good ways to identify people who are getting the disease, and use those people as subjects in studies to see how long it takes for symptoms to occur and in studies of drugs that may slow or stop the disease.
Researchers are finding simple and accurate ways to detect Alzheimer’s long before there are definite symptoms – in addition to spinal fluid tests they also have new PET scans that show the telltale amyloid plaques that are a unique feature of the disease. And they are testing hundreds of new drugs that, they hope, might slow or stop the relentless brain cell death that robs people of their memories and abilities to think and reason.
But the PET scans are not yet commercially available, while spinal fluid tests are. So the new results are giving rise to a difficult question: Should doctors offer, or patients accept, commercially available spinal tap tests to find a disease that is, as yet, untreatable? In the research studies, patients are often not told they may have the disease, but in practice in the real world, many may be told.
Some say it should be up to doctors and their patients. Others say doctors should refrain from using the spinal fluid test in their practices. It is not reliable enough – results can vary from lab to lab – and has only been studied in research settings where patients are carefully selected to have no other conditions, like strokes or depression, that could affect their memories.

“This is literally on the cutting edge of where the field is,” Dr. DeKosky said. “The field is moving fast. You can get a test that is approved by the F.D.A., and cutting edge doctors will use it.”

But, said Dr. John Trojanowski, a University of Pennsylvania researcher and senior author of the paper, given that people can get the test now, “how early do you want to label people?”
Some, like Dr. John Growdon, a neurology professor at the Massachusetts General Hospital who wrote an editorial accompanying the paper, said that decision is up to doctors and their patients.
Doctors might want to use the test in cases where they need to be sure a patient with symptoms of severe memory loss and loss of reasoning abilities has Alzheimer’s. And they might want to offer it to people with milder symptoms who really want to know if they have the devastating brain disease.
One drawback, though, is that spinal fluid is obtained with a spinal tap, and that procedure makes most doctors and many patients nervous. The procedure involves putting a needle in the spinal space and withdrawing a small amount of fluid.
Dr. Growdon and others say spinal taps are safe and not particularly painful for most people. But, Dr. Growdon said, there needs to be an education campaign to make people feel more comfortable about having them. He suggested that, since most family doctors and internists are not experienced with the test, there could be special spinal tap centers where they could sent patients.
The new study included more than 300 patients in their seventies, 114 with normal memories, 200 with memory problems, and 102 with Alzheimer’s disease. Their spinal fluid was analyzed for amyloid beta, which forms plaques in the brain, and for tau, another protein that accumulates in dead and dying nerve cells in the brain. To avoid bias, the researchers analyzing the data did not know anything about the clinical status of the subjects. Also, the subjects were not told what the tests showed.
Nearly every person with Alzheimer’s had the characteristic spinal fluid protein levels. Nearly three quarters of people with mild cognitive impairment, a memory impediment that can precede Alzheimer’s, had Alzheimer’s- like spinal fluid proteins. And every one of those patients developed Alzheimer’s within five years. And about a third of people with normal memories had spinal fluid indicating Alzheimer’s. Researchers suspect that those people will develop memory problems.
The prevailing hypothesis about Alzheimer’s says amyloid and tau accumulation are necessary for the disease and that stopping the proteins could stop the disease. But it is not yet known what happens when these proteins accumulate in the brains of people with normal memories. They might be a risk factor like high cholesterol levels. Many people with high cholesterol levels never have heart attacks. Or it might mean that Alzheimer’s has already started and if the person lives long enough he or she will get symptoms like memory loss with absolute certainty.
Many, like Dr. DeKosky, believe that when PET scans for amyloid become available, they will be used instead of spinal taps, in part because doctors and patients are more comfortable with brain scans.
And when – investigators optimistically are saying “when” these days – drugs are shown to slow or prevent the disease, the thought is that people will start having brain scans or spinal taps for Alzheimer’s as routinely as they might have colonoscopies or mammograms today.
For now, Dr. DeKosky said, the days when Alzheimer’s could be confirmed only at autopsy are almost over. And the time when Alzheimer’s could only be detected after most of the brain damage was done seem to be ending too.
“The new biomarkers in CSF have made the difference,” Dr. DeKosky said. “This confirms their accuracy in a very big way.”

Compartir esto en Facebook

Compartir web  

Somos información

Compartir es Amar a Distancia

  • WhatsApp
  • Tweet
  • Más
  • Telegram
  • Compartir en Tumblr
  • Imprimir
  • Correo electrónico

Echa un ojo a estas otras entradas:

Archivado en:Sin categoría Etiquetado con:Alzheimer's Disease, archives of neurology, biomarkers, John Morris Dr., spinal-fluid, Steven Dekosky Dr., Study, The New York Times

Acerca de Jesús Tj

"No olvides que la ciencia nos proporciona una forma de pensar racional, que modifica nuestro mundo a pasos agigantados y que, además, es bella." La Ciencia es Bella.

Haz tu pregunta o déjanos un comentario ;) Cancelar respuesta

Este sitio usa Akismet para reducir el spam. Aprende cómo se procesan los datos de tus comentarios.

Copyright © 2021 Alzheimer Universal · Desde 2008 · Inteligencia Colectiva en la Lucha Contra el Alzheimer · Jesús Tj - Ex-Cuidador - Con la colaboración desinteresada de Miguel Pujante de Desmárcate ¡YA!. | AVISO: La información médica que puedas encontrar en este sitio web se ofrece solamente con carácter formativo y educativo, y no pretende ni puede sustituir las opiniones, consejos y recomendaciones de un profesional sanitario. La información presente en un medio escrito, visual, etc. no puede sustituir el criterio de un profesional de la medicina. Las decisiones relativas a la salud deben ser tomadas por un profesional sanitario, considerando las características únicas del paciente. [Clic aquí para más INFORMACIÓN]

Este sitio web utiliza cookies para una mejor experiencia del usuario. Si continúas navegando estás dando tu consentimiento para la aceptación de las mencionadas cookies y la aceptación de nuestra política de cookies. Más información. Aceptar Reject Leer más
Privacidad y Política de Cookies

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necesarias
Siempre activado

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

No necesarias

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

loading Cancelar
La entrada no fue enviada. ¡Comprueba tus direcciones de correo electrónico!
Error en la comprobación del correo electrónico. Por favor, vuelve a intentarlo
Lo sentimos, tu blog no puede compartir entradas por correo electrónico.